Genmab | 売上原価



Cost Of Sales 変化する 日付
Agios Pharmaceuticals USD 1.08M 175K 2025-03
Almirall EUR 111.11M 4.18M 2024-12
Amarin USD 26.02M 1.3M 2024-09
Amgen USD 2.6B 507M 2025-03
argenx SE USD 80.8M 8.15M 2025-03
AstraZeneca USD 2.24B 484M 2025-03
Bayer EUR 5.62B 98M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Demant DKK 2.75B 1.46B 2024-12
Exelixis USD 19.17M 793K 2025-04
Fresenius Medical Care EUR 3.7B 117M 2025-03
Galapagos EUR 13.73M 99.2M 2025-03
Genmab DKK 42M 295M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
GN Store Nord DKK 1.8B 551M 2025-03
GRIFOLS EUR 1.09B 118.18M 2025-03
Hikma Pharmaceutical USD 895M 82M 2024-12
Insmed USD 21.28M 4.87M 2025-03
Lonza CHF 2.47B 532M 2024-12
Merck EUR 2.14B 184M 2025-03
Novartis USD 3.32B 90M 2024-12
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.89B 618M 2025-03
UCB EUR 901M 50M 2024-12



Genmab 売上原価 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Jun 2025.